Actionable insights straight to your inbox

Equities logo

Robert Ross

As Mauldin’s senior equity analyst, Robert specializes in qualitative and quantitative analysis: the math and “smell test” parts of stock research. Having been mentored by market veterans like Grant Williams, Tony Sagami, and Jared Dillian, he rose quickly through the ranks at Mauldin Economics and is one of the youngest chief analysts in the business. His forward-thinking, entrepreneurial bent and his Silicon Valley sensibilities (he lives in the San Francisco Bay Area) keep him watching for new sources of return. His readers find opportunities other investment managers miss.
History’s longest bull market keeps getting longer, and I don’t expect the trajectory to change anytime soon.
US healthcare spending will grow 5.5% annually through 2027, according to the Centers for Medicare and Medicaid Services.